R388-804-5. Diagnostic Criteria

In diagnosing tuberculosis, health care providers shall be expected to adhere to the standards listed in this document. (1) The department incorporates by reference the (IDSA/ATS/CDC) diagnostic and classification standards as described in the segment entitled Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children, published by the Centers for Disease Control and Prevention (CDC) in December 2016. (2) The department incorporates by reference: (a) Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis, published by the CDC in January 2009; (b) Availability of an Assay for Detecting Mycobacterium tuberculosis, Including Rifampin-Resistant Strains, and Considerations for Its Use, published by the CDC in October 2013; and (c) Consensus statement on the use of Cepheid Xpert MTB/RIF assay in making decisions to discontinue airborne infection isolation in healthcare settings, published by National Tuberculosis Controllers Association and Association of Public Health Laboratories in April 2016. (3) The department incorporates by reference the CDC diagnostic and classification standards for use of Interferon Gamma Release Assays as described in the document entitled, Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection, United States, 2010, published by the CDC.